Clinical Trial Update: Addition of Tobramycin Inhalation in the Treatment of Ventilator Associated Pneumonia [Phase 4]

View source ↗

Summary

Phase 4 trial investigating addition of tobramycin inhalation for treating ventilator-associated pneumonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• TOBRAMYCIN INHALATION (TOBRAMYCIN)

Snippet

Sponsor: Erasmus Medical Center | Conditions: Ventilator Associated Pneumonia (VAP) | Phase 4 | Status: COMPLETED